...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Cardiac Decompensation Following Verapamil Therapy in Infants with Supraventricular Tachycardia
【24h】

Cardiac Decompensation Following Verapamil Therapy in Infants with Supraventricular Tachycardia

机译:维拉帕米治疗婴儿室上性心动过速后的心脏代偿失调

获取原文
           

摘要

Three infants with supraventricular tachycardia and congestive cardiac failure were given verapamil intravenously. In two of the infants, the rhythm was converted to sinus, but the third infant required direct current cardioversion. However, each infant demonstrated hemodynamic decompensation shortly after verapamil administration and required cardiopulmonary resuscitation. All three patients were stabilized and their tachycardia was controlled with digoxin. All three were doing well at the time of follow-up evaluation, and there was no evidence of structural heart disease. The risk of cardiac decompensation in infants with supraventricular tachycardia and congestive cardiac failure should be kept in mind prior to administration of verapamil. Alternative methods for conversion of supraventricular tachycardia should be considered.
机译:对三例室上性心动过速和充血性心力衰竭的婴儿进行了维拉帕米静脉注射。在其中两个婴儿中,心律转变为鼻窦,但第三个婴儿需要直流电复律。但是,每位婴儿在服用维拉帕米后不久均表现出血流动力学失代偿,需要进行心肺复苏。三名患者均稳定下来,地高辛控制了他们的心动过速。随访评估时,三者均表现良好,没有证据表明存在结构性心脏病。在服用维拉帕米之前,应牢记患有室上性心动过速和充血性心力衰竭的婴儿发生心脏代偿失调的风险。应当考虑采用其他方法来转化室上性心动过速。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号